Tapewire

Nasdaq · USD

VREX

Varex Imaging Corp

Export transactions ↓
Tapewire entity
5135
SEC CIK
0001681622
Parsed reports
278

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 12, 2019 Filed Feb 14, 2019 19:31 UTC Exercise / conversionDeferred Stock Units · Derivative 6,358 $0.00 $0.00
Disclosure

SEC source: 0001681622-19-000010 · wf-form4_155019066530169.xml · derivative · entry 2

NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,358 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 12, 2019.

F2 · derivative.expiration_date: Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 12, 2019.

Read SEC document
February 12, 2019 Filed Feb 14, 2019 19:31 UTC Exercise / conversionCommon Stock 6,358 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-19-000010 · wf-form4_155019066530169.xml · nonDerivative · entry 1

NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,829

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 12, 2019 Filed Feb 14, 2019 19:41 UTC Exercise / conversionDeferred Stock Units · Derivative 6,358 $0.00 $0.00
Disclosure

SEC source: 0001681622-19-000012 · wf-form4_155019129527013.xml · derivative · entry 3

REINHARDT ERICH R · CIK 0001555958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,358 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 12, 2019.

F3 · derivative.expiration_date: Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 12, 2019.

Read SEC document
February 12, 2019 Filed Feb 14, 2019 19:41 UTC Tax withholdingCommon Stock 1,272 $31.42 $39,966.24
Disclosure

SEC source: 0001681622-19-000012 · wf-form4_155019129527013.xml · nonDerivative · entry 2

REINHARDT ERICH R · CIK 0001555958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,075

F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Deferred Stock Units reported herein.

Read SEC document
February 12, 2019 Filed Feb 14, 2019 19:41 UTC Exercise / conversionCommon Stock 6,358 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-19-000012 · wf-form4_155019129527013.xml · nonDerivative · entry 1

REINHARDT ERICH R · CIK 0001555958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,347

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
September 14, 2018 Filed Sep 18, 2018 18:44 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 11,155 $0.00 Strike: $19.21 $0.00
Disclosure

SEC source: 0001681622-18-000035 · wf-form4_153731067861809.xml · derivative · entry 2

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,155 shares

Expires 2018-11-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted in connection with Varex's spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested.

Read SEC document
September 14, 2018 Filed Sep 18, 2018 18:44 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionCommon Stock 11,155 $19.21 $214,287.55
Disclosure

SEC source: 0001681622-18-000035 · wf-form4_153731067861809.xml · nonDerivative · entry 1

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,789

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 564 shares purchased on on April 27, 2018 under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Also includes 20 shares inadvertently omitted from a prior Form 4 filing.

Read SEC document
August 17, 2018 Filed Aug 17, 2018 18:15 UTC
VERHOEF CLARENCE RSVP & Chief Financial Officer
PurchaseCommon Stock 3,300 $29.58 $97,614.00
Disclosure

SEC source: 0001681622-18-000033 · wf-form4_153454409633926.xml · nonDerivative · entry 1

VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,925

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $29.48 to $29.64 per share, inclusive. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 671 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.

Read SEC document
August 10, 2018 Filed Aug 13, 2018 19:07 UTC
SANYAL SUNNYDirector · President and CEO
PurchaseCommon Stock 7,000 $28.18 $197,260.00
Disclosure

SEC source: 0001681622-18-000031 · wf-form4_153420164393520.xml · nonDerivative · entry 1

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,755

F1 · price: The price reported in Colum 4 is a weighted average price. These shares were purchased in three transactions:1,300 shares at a price of $28.17, 3,400 shares at a price of $28.18 and 2,300 shares at a price of $28.18.

F2 · balance_after: Includes 746 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.

Read SEC document
August 07, 2018 Filed Aug 9, 2018 21:34 UTC PurchaseCommon Shares 10,000 $28.39 $283,900.00
Disclosure

SEC source: 0001681622-18-000028 · wf-form4_153385042927150.xml · nonDerivative · entry 1

Rosebrough Walter M Jr · CIK 0001413087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions: 5,000 shares at a price of $28.00 and 5,000 shares at a price of $28.78.

F2 · balance_after: These 14,000 Common Shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit.

Read SEC document
July 02, 2018 Filed Jul 5, 2018 18:46 UTC
Giambattista Brian WSVP and GM, X-ray Detectors
SaleCommon Shares 570 $36.66 $20,894.89
Disclosure

SEC source: 0001681622-18-000022 · wf-form4_153083077772608.xml · nonDerivative · entry 1

Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 31, 2018. These shares were sold at prices ranging from $36.39 to $36.77.

Read SEC document
June 05, 2018 Filed Jun 7, 2018 17:16 UTC
LaCasce Carl E.SVP, Sales & Marketing
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 11,155 $0.00 Strike: $19.21 $0.00
Disclosure

SEC source: 0001681622-18-000020 · wf-form4_152840619676269.xml · derivative · entry 3

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,155 shares

Expires 2018-11-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested.

Read SEC document
June 05, 2018 Filed Jun 7, 2018 17:16 UTC
LaCasce Carl E.SVP, Sales & Marketing
SaleCommon Stock 11,155 $37.42 $417,400.02
Disclosure

SEC source: 0001681622-18-000020 · wf-form4_152840619676269.xml · nonDerivative · entry 2

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,816

F2 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2018. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.15 to $37.86.

Read SEC document
June 05, 2018 Filed Jun 7, 2018 17:16 UTC
LaCasce Carl E.SVP, Sales & Marketing
Exercise / conversionCommon Stock 11,155 $19.21 $214,287.55
Disclosure

SEC source: 0001681622-18-000020 · wf-form4_152840619676269.xml · nonDerivative · entry 1

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,971

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 236 shares purchased on April 27, 2018 under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.

Read SEC document
May 30, 2018 Filed May 31, 2018 17:58 UTC SaleCommon Stock 1,500 $37.96 $56,941.50
Disclosure

SEC source: 0001214659-18-004193 · marketforms-42154.xml · nonDerivative · entry 1

NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,471

Read SEC document
May 14, 2018 Filed May 16, 2018 20:16 UTC
Yankton Kevin BruceChief Accounting Officer
SaleCommon Stock 862 $37.00 $31,894.00
Disclosure

SEC source: 0001214659-18-003806 · marketforms-42011.xml · nonDerivative · entry 1

Yankton Kevin Bruce · CIK 0001697197 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2018.

Read SEC document
April 20, 2018 Filed May 9, 2018 19:58 UTC GrantDeferred Stock Units · Derivative 3,603 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-003493 · marketforms-41890.xml · derivative · entry 1

Rosebrough Walter M Jr · CIK 0001413087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,603

Underlying: Common Stock · 3,603 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units will vest in full on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the next annual meeting, subject to the reporting person serving on the board of the company through the vesting date.

F2 · derivative.expiration_date: These Deferred Stock Units will vest in full on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the next annual meeting, subject to the reporting person serving on the board of the company through the vesting date.

Read SEC document
April 16, 2018 Filed Apr 17, 2018 17:33 UTC
Honeysett Kimberley E.SVP and General Counsel
SaleCommon Stock 2,000 $37.68 $75,352.00
Disclosure

SEC source: 0001214659-18-002863 · marketforms-41746.xml · nonDerivative · entry 1

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 916

F1 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 15, 2018.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC
Giambattista Brian WSVP and GM, X-ray Detectors
GrantRestricted Stock Units · Derivative 4,811 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001420 · marketforms-41077.xml · derivative · entry 2

Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,811

Underlying: Common Stock · 4,811 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

F3 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC
Giambattista Brian WSVP and GM, X-ray Detectors
GrantNon-Qualified Stock Option (right to buy) · Derivative 15,113 $0.00 Strike: $37.10 $0.00
Disclosure

SEC source: 0001214659-18-001420 · marketforms-41077.xml · derivative · entry 1

Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,113

Underlying: Common Stock · 15,113 shares

Expires 2025-02-15

F2 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four year vesting schedule. 25% of the total number of options vests on February 15, 2019 and the remaining options vests monthly thereafter on a pro rata basis.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 21:15 UTC
Honeysett Kimberley E.SVP and General Counsel
GrantNon-Qualified Stock Option (right to buy) · Derivative 13,875 $0.00 Strike: $37.10 $0.00
Disclosure

SEC source: 0001214659-18-001439 · marketforms-41069.xml · derivative · entry 10

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,875

Underlying: Common Stock · 13,875 shares

Expires 2025-02-15

F8 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of options vests one year from grant date, and the remaining options vests monthly thereafter on a pro rata basis.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 21:15 UTC
Honeysett Kimberley E.SVP and General Counsel
GrantRestricted Stock Units · Derivative 4,416 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001439 · marketforms-41069.xml · derivative · entry 9

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,416

Underlying: Common Stock · 4,416 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F7 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

F7 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 21:15 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionRestricted Stock Units · Derivative 1,104 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001439 · marketforms-41069.xml · derivative · entry 8

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,105

Underlying: Common Stock · 1,104 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F6 · derivative.exercise_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

F6 · derivative.expiration_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 21:15 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionRestricted Stock Units · Derivative 1,356 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001439 · marketforms-41069.xml · derivative · entry 7

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,356 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F5 · derivative.exercise_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

F5 · derivative.expiration_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 21:15 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionRestricted Stock Units · Derivative 1,307 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001439 · marketforms-41069.xml · derivative · entry 6

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,921

Underlying: Common Stock · 1,307 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 21:15 UTC
Honeysett Kimberley E.SVP and General Counsel
Tax withholdingCommon Stock 1,242 $37.10 $46,078.20
Disclosure

SEC source: 0001214659-18-001439 · marketforms-41069.xml · nonDerivative · entry 4

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,916

F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 21:15 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionCommon Stock 1,104 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-18-001439 · marketforms-41069.xml · nonDerivative · entry 3

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 21:15 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionCommon Stock 1,356 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-18-001439 · marketforms-41069.xml · nonDerivative · entry 2

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,054

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 21:15 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionCommon Stock 1,307 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-18-001439 · marketforms-41069.xml · nonDerivative · entry 1

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,698

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F2 · balance_after: Includes 391 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:51 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
GrantNon-Qualified Stock Option (right to buy) · Derivative 14,409 $0.00 Strike: $37.10 $0.00
Disclosure

SEC source: 0001214659-18-001421 · marketforms-41070.xml · derivative · entry 9

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,409

Underlying: Common Stock · 14,409 shares

Expires 2025-02-15

F8 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of options vests one year from grant date, and the remaining options vests monthly thereafter on a pro rata basis.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:51 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
GrantRestricted Stock Units · Derivative 4,586 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001421 · marketforms-41070.xml · derivative · entry 8

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,586

Underlying: Common Stock · 4,586 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F7 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

F7 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:51 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionRestricted Stock Units · Derivative 1,644 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001421 · marketforms-41070.xml · derivative · entry 7

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,644 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F6 · derivative.exercise_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

F6 · derivative.expiration_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:51 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionRestricted Stock Units · Derivative 1,766 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001421 · marketforms-41070.xml · derivative · entry 6

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,767

Underlying: Common Stock · 1,766 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F5 · derivative.exercise_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

F5 · derivative.expiration_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:51 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionRestricted Stock Units · Derivative 1,520 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001421 · marketforms-41070.xml · derivative · entry 5

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,561

Underlying: Common Stock · 1,520 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:51 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Tax withholdingCommon Stock 2,246 $37.10 $83,326.60
Disclosure

SEC source: 0001214659-18-001421 · marketforms-41070.xml · nonDerivative · entry 4

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,050

F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:51 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionCommon Stock 1,644 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-18-001421 · marketforms-41070.xml · nonDerivative · entry 3

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,296

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:51 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionCommon Stock 1,766 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-18-001421 · marketforms-41070.xml · nonDerivative · entry 2

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,652

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:51 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionCommon Stock 1,520 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-18-001421 · marketforms-41070.xml · nonDerivative · entry 1

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,886

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F2 · balance_after: Includes 548 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC
LaCasce Carl E.SVP, Sales & Marketing
GrantNon-Qualified Stock Option (right to buy) · Derivative 15,095 $0.00 Strike: $37.10 $0.00
Disclosure

SEC source: 0001214659-18-001418 · marketforms-41072.xml · derivative · entry 9

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,095

Underlying: Common Stock · 15,095 shares

Expires 2025-02-16

F8 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of options vests one year from grant date, and the remaining options vests monthly thereafter on a pro rata basis.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC
LaCasce Carl E.SVP, Sales & Marketing
GrantRestricted Stock Units · Derivative 4,805 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001418 · marketforms-41072.xml · derivative · entry 8

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,805

Underlying: Common Stock · 4,805 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F7 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

F7 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC
LaCasce Carl E.SVP, Sales & Marketing
Exercise / conversionRestricted Stock Units · Derivative 1,664 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001418 · marketforms-41072.xml · derivative · entry 7

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,664 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F6 · derivative.exercise_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

F6 · derivative.expiration_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC
LaCasce Carl E.SVP, Sales & Marketing
Exercise / conversionRestricted Stock Units · Derivative 1,766 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001418 · marketforms-41072.xml · derivative · entry 6

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,767

Underlying: Common Stock · 1,766 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F5 · derivative.exercise_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

F5 · derivative.expiration_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC
LaCasce Carl E.SVP, Sales & Marketing
Exercise / conversionRestricted Stock Units · Derivative 1,592 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001418 · marketforms-41072.xml · derivative · entry 5

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,479

Underlying: Common Stock · 1,592 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC
LaCasce Carl E.SVP, Sales & Marketing
Tax withholdingCommon Stock 1,529 $37.10 $56,725.90
Disclosure

SEC source: 0001214659-18-001418 · marketforms-41072.xml · nonDerivative · entry 4

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,580

F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC
LaCasce Carl E.SVP, Sales & Marketing
Exercise / conversionCommon Stock 1,664 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-18-001418 · marketforms-41072.xml · nonDerivative · entry 3

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,109

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC
LaCasce Carl E.SVP, Sales & Marketing
Exercise / conversionCommon Stock 1,766 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-18-001418 · marketforms-41072.xml · nonDerivative · entry 2

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC
LaCasce Carl E.SVP, Sales & Marketing
Exercise / conversionCommon Stock 1,592 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-18-001418 · marketforms-41072.xml · nonDerivative · entry 1

LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F2 · balance_after: Includes 229 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan

Read SEC document
February 15, 2018 Filed Feb 21, 2018 01:54 UTC GrantDeferred Stock Units · Derivative 4,312 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001427 · marketforms-41083.xml · derivative · entry 1

TSINGOS CHRISTINE A · CIK 0001278861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,312

Underlying: Common Stock · 4,312 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units vest 100% 1 year from grant date (February 15, 2018). Vested shares will be delivered to the reporting person upon the earlier of (i) the NEDs termination of service for any reason, (ii) 3 years from grant date, (iii) a change in control, or (iv) upon death.

F2 · derivative.expiration_date: These Deferred Stock Units vest 100% 1 year from grant date (February 15, 2018). Vested shares will be delivered to the reporting person upon the earlier of (i) the NEDs termination of service for any reason, (ii) 3 years from grant date, (iii) a change in control, or (iv) upon death.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:56 UTC GrantDeferred Stock Units · Derivative 5,929 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001434 · marketforms-41082.xml · derivative · entry 1

NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,929

Underlying: Common Stock · 5,929 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units vest 100% 1 year from grant date (February 15, 2018). Vested shares will be delivered to the reporting person upon the earlier of (i) the NEDs termination of service for any reason, (ii) 3 years from grant date, (iii) a change in control, or (iv) upon death.

F2 · derivative.expiration_date: These Deferred Stock Units vest 100% 1 year from grant date (February 15, 2018). Vested shares will be delivered to the reporting person upon the earlier of (i) the NEDs termination of service for any reason, (ii) 3 years from grant date, (iii) a change in control, or (iv) upon death.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:57 UTC
WILSON DOW RDirector
Exercise / conversionDeferred Stock Units · Derivative 5,148 $0.00 $0.00
Disclosure

SEC source: 0001214659-18-001437 · marketforms-41088.xml · derivative · entry 2

WILSON DOW R · CIK 0001313996 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,148 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: These shares vested on February 15, 2018.

F3 · derivative.expiration_date: These shares vested on February 15, 2018.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.